Adam Belley
- Infectious Diseases top 5%
- Molecular Medicine top 1%
- Pharmacology top 5%
- Molecular Biology
- Epidemiology
- Co-authors
- Greg MoeckFrancis F. ArhinGeoffrey A. McKayThomas ParrIngrid SarmientoSylvain BeaulieuTerry J. BeveridgePhilipp Knechtle
- Topics
- Antibiotics Pharmacokinetics and Efficacy (23 papers)Antimicrobial Resistance in Staphylococcus (17 papers)Antibiotic Resistance in Bacteria (15 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Adam Belley
29 papers receiving 872 citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 466
- Molecular Medicine 344
- Pharmacology 336
- Molecular Biology 264
- Epidemiology 167
Countries citing papers authored by Adam Belley
This map shows the geographic impact of Adam Belley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Belley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Belley more than expected).
Fields of papers citing papers by Adam Belley
This network shows the impact of papers produced by Adam Belley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Belley. The network helps show where Adam Belley may publish in the future.
Co-authorship network of co-authors of Adam Belley
This figure shows the co-authorship network connecting the top 25 collaborators of Adam Belley. A scholar is included among the top collaborators of Adam Belley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Belley. Adam Belley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 61 | |
| 6 | 24 | |
| 7 | 27 | |
| 8 | 2 | |
| 9 | 12 | |
| 10 | 6 | |
| 11 | 10 | |
| 12 | 24 | |
| 13 | 96 | |
| 14 | 16 | |
| 15 | 114 | |
| 16 | 72 | |
| 17 | 32 | |
| 18 | 1 | |
| 19 | 17 | |
| 20 | 45 |
About Adam Belley
Adam Belley is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 32 papers that have together received 928 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and Antibiotic Resistance in Bacteria (15 papers). The work is most often cited by research in Molecular Medicine (344 citations), Applied Microbiology and Biotechnology (90 citations) and Infectious Diseases (466 citations). Adam Belley has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Greg Moeck, Francis F. Arhin, Geoffrey A. McKay, Thomas Parr, Ingrid Sarmiento, Sylvain Beaulieu, Terry J. Beveridge, Philipp Knechtle, Daniel F. Sahm and Deborah C. Draghi. Their work appears in journals such as JAMA, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.